title: Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine.
authors.forename: Mathilde
authors.initials: M
authors.lastname: Gavillet
authors.forename: Jasmine
authors.initials: J
authors.lastname: Noetzli
authors.forename: Sabine
authors.initials: S
authors.lastname: Blum
authors.forename: Michel A
authors.initials: MA
authors.lastname: Duchosal
authors.forename: Olivier
authors.initials: O
authors.lastname: Spertini
authors.forename: Jean-Francois
authors.initials: JF
authors.lastname: Lambert
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use*; D001803:Blood Transfusion; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001374:Azacitidine